Skip to main content
. 2018 Dec 11;9(97):37042–37053. doi: 10.18632/oncotarget.26455

Table 2. Pharmacokinetic parameters from six dogs treated with a single EC0531 dose of 0.28 mg/kg given intravenously.

Dog # t1/2 (min) Tmax (min) Cmax (ng/mL) C0 (ng/mL) AUClast (hr*ng/mL) AUCinf (hr*ng/mL) Vz (L/kg) Cl (L/hr/kg) Tmax (min)^ Cmax (ng/mL)^
1 22.0 2.0 4400 4971 2299 2305 0.0643 0.121 10.0 2.0
2 19.9 2.0 5270 6187 2801 2806 0.0477 0.100 10.0 4.0
3 26.3 2.0 2630 2840 1552 1563 0.1134 0.179 10.0 3.2
4 26.5 2.0 2920 3335 1679 1681 0.1062 0.167 10.0 2.2
5 26.4 2.0 3300 3641 2082 2084 0.0853 0.134 2.0 1.8
6 27.3 2.0 2410 2976 939 941 0.1956 0.298 30.0 0.7
Avg 24.7 2.0 3488 3992 1892 1896 0.102 0.167 12.0 2.3
SD 3.03 0 1119 1319 647 648 0.052 0.071 9.4 1.1

The dogs included (in order in the table): a 15 year old, 23 kg, neutered male Norwegian Elkhound; a 9 year old, 27 kg, spayed female mixed breed dog; a 13 year old, 7 kg, spayed female Tibetan Terrier; a 14 year old, 13 kg, neutered male Fox Terrier; an 11 year old, 17 kg, spayed female Border Collie; and a 9 year old, 11 kg, spayed female Scottish Terrier.

^EC0347 (free drug) data.